Abstract
CLL-354 First Line Treatment of Chronic Lymphocytic Leukemia (CLL) Patients With Obinutuzumab Based Therapy: Single-Center Experience
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/s2152-2650(23)01109-6
Publication Date: Aug 31, 2023 |
CLL-354 First Line Treatment of Chronic Lymphocytic Leukemia (CLL) Patients With Obinutuzumab Based Therapy: Single-Center Experience
Join us for a 30 min session where you can share your feedback and ask us any queries you have